Taraxeryl acetate

Details

Top
Internal ID c7e45989-2d2e-4662-8e7f-2214fcdbbd07
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesterterpenoids > Scalarane sesterterpenoids
IUPAC Name (4,4,6a,6a,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl) acetate
SMILES (Canonical) CC(=O)OC1CCC2(C(C1(C)C)CCC3(C2CCC4(C3=CCC5(C4CC(CC5)(C)C)C)C)C)C
SMILES (Isomeric) CC(=O)OC1CCC2(C(C1(C)C)CCC3(C2CCC4(C3=CCC5(C4CC(CC5)(C)C)C)C)C)C
InChI InChI=1S/C32H52O2/c1-21(33)34-26-13-17-30(7)22(28(26,4)5)11-15-31(8)23-10-14-29(6)19-18-27(2,3)20-25(29)32(23,9)16-12-24(30)31/h10,22,24-26H,11-20H2,1-9H3
InChI Key YWJGYBXHXATAQY-UHFFFAOYSA-N
Popularity 7 references in papers

Physical and Chemical Properties

Top
Molecular Formula C32H52O2
Molecular Weight 468.80 g/mol
Exact Mass 468.396730897 g/mol
Topological Polar Surface Area (TPSA) 26.30 Ų
XlogP 9.90
Atomic LogP (AlogP) 8.74
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 1

Synonyms

Top
2189-80-2
(4,4,6a,6a,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl) acetate
FT-0775541

2D Structure

Top
2D Structure of Taraxeryl acetate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 1.0000 100.00%
Caco-2 - 0.5285 52.85%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability - 0.5143 51.43%
Subcellular localzation Mitochondria 0.7182 71.82%
OATP2B1 inhibitior - 0.7252 72.52%
OATP1B1 inhibitior + 0.8604 86.04%
OATP1B3 inhibitior + 0.9480 94.80%
MATE1 inhibitior - 0.8200 82.00%
OCT2 inhibitior - 0.5750 57.50%
BSEP inhibitior + 0.8751 87.51%
P-glycoprotein inhibitior + 0.6355 63.55%
P-glycoprotein substrate - 0.8771 87.71%
CYP3A4 substrate + 0.6850 68.50%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8603 86.03%
CYP3A4 inhibition - 0.8326 83.26%
CYP2C9 inhibition - 0.8546 85.46%
CYP2C19 inhibition + 0.7404 74.04%
CYP2D6 inhibition - 0.9432 94.32%
CYP1A2 inhibition - 0.8654 86.54%
CYP2C8 inhibition - 0.6623 66.23%
CYP inhibitory promiscuity - 0.8356 83.56%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9243 92.43%
Carcinogenicity (trinary) Non-required 0.4710 47.10%
Eye corrosion - 0.9873 98.73%
Eye irritation - 0.9057 90.57%
Skin irritation + 0.5106 51.06%
Skin corrosion - 0.9867 98.67%
Ames mutagenesis - 0.6900 69.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7790 77.90%
Micronuclear - 0.7700 77.00%
Hepatotoxicity - 0.7500 75.00%
skin sensitisation + 0.6846 68.46%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity + 0.8222 82.22%
Mitochondrial toxicity + 0.5500 55.00%
Nephrotoxicity - 0.5777 57.77%
Acute Oral Toxicity (c) III 0.8704 87.04%
Estrogen receptor binding + 0.8335 83.35%
Androgen receptor binding + 0.6243 62.43%
Thyroid receptor binding + 0.6720 67.20%
Glucocorticoid receptor binding + 0.7946 79.46%
Aromatase binding + 0.7375 73.75%
PPAR gamma + 0.6684 66.84%
Honey bee toxicity - 0.8090 80.90%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity - 0.5405 54.05%
Fish aquatic toxicity + 0.9965 99.65%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 96.83% 96.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 96.37% 94.45%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.46% 91.11%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 87.44% 82.69%
CHEMBL253 P34972 Cannabinoid CB2 receptor 87.30% 97.25%
CHEMBL1994 P08235 Mineralocorticoid receptor 86.54% 100.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 86.11% 97.09%
CHEMBL5608 Q16288 NT-3 growth factor receptor 85.18% 95.89%
CHEMBL241 Q14432 Phosphodiesterase 3A 82.08% 92.94%
CHEMBL2581 P07339 Cathepsin D 81.29% 98.95%
CHEMBL340 P08684 Cytochrome P450 3A4 80.57% 91.19%

Cross-Links

Top
PubChem 5205968
LOTUS LTS0047312
wikiData Q104202147